15:59 Apr 29

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2067.10
-38.30 (-1.82%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2067.10
-38.30 (-1.82%)
15:59 Apr 29
Quality
image/svg+xml

84/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

52/100
Technically Neutral

Strength

14

Weakness

3

Opportunity

1

Threats

0

13.39 %

ROE %

7.97 %

ROA %

62.82

EPS

315.41

BVPS

9.56 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
15162.96 16405.48 16641.66 20010.82 22001.56
Operating Expenses +
12596.08 16118.26 14843.54 16200.3 17067.48
Raw Material
5847.1 6679.56 6626.03 7100.91 7170.4
Increase Decrease in Cost
-484.86 -198.32 153.73 -457.44 -440.51
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2825.9 2989.3 3087.15 3494.57 3863.17
Miscellaneous Expenses
9762.56 13535.42 10853.07 11979.7 6474.42
Operating Profit
2566.88 287.22 1798.12 3810.52 4934.08
Other Income
136.29 141.69 73.36 120.17 193.03
Depreciation
887.41 1658.71 880.69 1196.81 1233.18
Interest
140.64 142.77 274.3 311.61 277.06
Profit before tax and exceptio..
1675.12 -1372.57 716.49 2422.27 3616.87
Exceptional Items
0 0 0 0 0
PBT
1675.12 -1372.57 716.49 2422.27 3616.87
Provision for Taxation
448.52 137.15 268.8 486.7 724.77
Net Profit
1226.6 -1509.72 447.69 1935.57 2892.1
NET Profit after MI
1216.53 -1528.04 430.08 1914.48 2868.53
EPS
26.72 -33.65 9.41 41.87 62.92
Operating Profit Margin (%)
16.93 1.75 10.8 19.04 22.43
Net Profit Margin (%)
8.02 -9.31 2.58 9.57 13.04

ShareHolding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 46.90 47.00 47.00 47.00 47.00
FII 21.50 22.00 21.50 19.30 18.30
MF 17.60 16.90 16.90 16.20 16.80
Public 6.20 6.30 6.40 6.90 6.90
Others 0.00 0.00 0.00 0.00 0.00
Others 7.80 7.80 8.20 10.60 11.00
Shareholder Shares Holding %

Download Our App On: